
CareDx, Inc CDNA
€ 18.21
0.66%
Geschäftsbericht 2025
hinzugefügt 25.02.2026
CareDx, Inc DSO 2011-2026 | CDNA
DSO Jährlich CareDx, Inc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.5 | 63.2 | 76.4 | 71.5 | 58.1 | 55.7 | 69.1 | 46.5 | 22.6 | 24.9 | 30.7 | 35.9 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 76.4 | 22.6 | 50.5 |
DSO Vierteljährlich CareDx, Inc
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.5 | 73.1 | 73.3 | - | 73.1 | 62.5 | 70.4 | - | 70.2 | 72 | 74.2 | - | 40.5 | 37 | 71.9 | - | 62.9 | 56.2 | 52.8 | - | 59.2 | 75.6 | 69.8 | 61.3 | 64.9 | 69.8 | 59.4 | 37.9 | 42 | 50 | 41.4 | 21.8 | 22.4 | 22.7 | 22.7 | 30.8 | 34.6 | 31.4 | 33.9 | 32.5 | 30.2 | 30.3 | 32 | 30.8 | 36.9 | 36.2 | 38.2 | 35.4 | 35.7 | 19 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 75.6 | 19 | 47.8 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
63.8 | $ 116.96 | 1.23 % | $ 35.6 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 1.72 | 2.99 % | $ 2.29 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 25.0 | 2.21 % | $ 694 M | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 16.33 | 0.12 % | $ 494 M | ||
|
Illumina
ILMN
|
61.3 | $ 128.0 | 0.09 % | $ 20.4 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 171.98 | 1.3 % | $ 8.52 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
46.1 | $ 88.84 | -0.08 % | $ 11.1 B | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 84.31 | -0.03 % | $ 5.69 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.98 | -2.37 % | $ 8.76 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 412.77 | 0.54 % | $ 11.9 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 7.05 | - | $ 294 M | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.6 | 0.58 % | $ 2.08 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.12 | -0.93 % | $ 4.87 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.33 | 0.55 % | $ 388 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 101.21 | -0.94 % | $ 8.35 B | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 263.81 | 0.03 % | $ 21.9 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 473.8 | 0.9 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.64 | -1.34 % | $ 61.9 M | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.41 | 1.45 % | $ 1.08 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 61.16 | 0.36 % | $ 3.66 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.91 | 2.72 % | $ 455 M | ||
|
Natera
NTRA
|
81.5 | $ 206.02 | 1.11 % | $ 20.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 196.49 | 0.14 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | ||
|
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M |